Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

arXiv:2512.15889 · Physical Review A

Quantum Algorithms for Photoreactivity in Cancer-Targeted Photosensitizers

Yanbing Zhou, Pablo A. M. Casares, Diksha Dhawan, Ignacio Loaiza, Soran Jahangiri, Robert A. Lang, Juan Miguel Arrazola, Stepan Fomichev

quant-phSubmitted Dec 17, 2025• Announced Dec 19, 2025• 4 citations
arXivHTMLPDF

Abstract

Photodynamic therapy (PDT) is a targeted cancer treatment that uses light-activated photosensitizers to generate reactive oxygen species that selectively destroy tumor cells, generally causing less collateral damage than conventional treatments. However, its clinical success hinges on the availability of photosensitizers with strong optical sensitivity and high efficiency in generating reactive oxygen species. While classical computational methods have provided useful insights into photosensitizer design, they struggle to scale and often lack the accuracy needed for these simulations. In this work, we show how fault-tolerant quantum algorithms can be used to identify promising photosensitizer candidates for PDT. To predict photosensitizer performance, we assess two computational properties. First, we quantify light sensitivity by calculating the cumulative absorption in the therapeutic window with a threshold projection algorithm. Second, we determine the efficiency of reactive oxygen generation by estimating intersystem crossing (ISC) rates using the evolution-proxy approach, complemented by a vibronic dynamic treatment where appropriate. We apply these algorithms to a clinically relevant and actively pursued class of photosensitizers, BODIPY derivatives, including heavy-atom and transition-metal-substituted systems that are challenging for classical methods. Our resource estimates, obtained with PennyLane, suggest that systems with active spaces ranging from 11 to 45 spatial orbitals can be simulated using $180$-$350$ logical qubits and Toffoli gate depths between $10^7$ and $10^9$, placing our algorithms within reach of realistic fault-tolerant quantum devices. This paves the way to an efficient quantum-based workflow for designing photosensitizers that can accelerate the discovery of new PDT agents.

Related papers

Quantum Resource Assay for the Grid-Based Simulation of the Photodynamics of Pyrazine

Xiaoning Feng, Hans Hon Sang Chan, David P. Tew

We establish and analyse the performance and resource requirements of an end-to-end fault-tolerant quantum algorithm for computing the absorption spectrum and population dynamics of photoexcited pyrazine. The quantum circuit construction consists of initial state preparation using uniformly controlled rotations, the time-dependent Hamiltonian propagation based on the grid-based Split Operator Quantum Fourier Transform (SO-QFT) method, and cost-effective measurements including statistical and canonical phase estimation. We use classical emulations to validate the quantum resources required for the task, and propose generalised formulae for the qubit count and gate depth calculation. Simulating the vibronic dynamics of pyrazine in a low-dimensional abstraction requires 17-qubit circuits with a gate depth of $\mathcal{O}(10^5)$, whereas a full-dimensional simulation of pyrazine in 24 modes requires at least 97-qubit circuits with a gate depth of $\mathcal{O}(10^6)$. Our work provides a foundational framework for understanding high-dimensional wavepacket-based quantum simulations of photo-induced dynamics and vibronic spectra, anticipating future applications in the simulation of even larger molecular systems on fault-tolerant quantum computers.

arXiv:2506.08609•Jun 10, 2025•3 citations

A Perspective on Quantum Computing Applications in Quantum Chemistry Using 25–100 Logical Qubits

Yuri Alexeev, Víctor S. Batista, Nicholas P. Bauman +27 more

The intersection of quantum computing and quantum chemistry represents a promising frontier for achieving quantum utility in domains of both scientific and societal relevance. Owing to the exponential growth of classical resource requirements for simulating quantum systems, quantum chemistry has long been recognized as a natural candidate for quantum computation. This perspective focuses on identifying scientifically meaningful use cases where early fault-tolerant quantum computers, which are considered to be equipped with approximately 25-100 logical qubits, could deliver tangible impact. While recent advances in classical computing have pushed the boundaries of tractable simulations to unprecedented scales, this logical-qubit regime represents the first window where quantum devices can pursue qualitatively distinct strategies, such as polynomial-scaling phase estimation, direct simulation of quantum dynamics, and active-space embedding, that remain challenging for classical solvers, such as multireference charge-transfer and conical-intersection states central to photochemistry and materials design. We highlight near-term opportunities in algorithm and software design, discuss representative chemical problems suited for quantum acceleration, and propose strategic roadmaps and collaborative pathways for advancing practical quantum utility in quantum chemistry.

arXiv:2506.19337•Journal of Chemical Theory and Computation•Nov 11, 2025•31 citations

Quantum algorithm for simulating non-adiabatic dynamics at metallic surfaces

Robert A. Lang, Paarth Jain, Juan Miguel Arrazola +1 more

Non-adiabatic dynamics at molecule-metal interfaces govern diverse and technologically important phenomena, from heterogeneous catalysis to dye-sensitized solar energy conversion and charge transport across molecular junctions. Realistic modeling of such dynamics necessitates taking into account various charge and energy transfer channels involving the coupling of nuclear motion with a very large number of electronic states, leading to prohibitive cost using classical computational methods. In this work we introduce a generalization of the Anderson-Newns Hamiltonian and develop a highly optimized quantum algorithm for simulating the non-adiabatic dynamics of realistic molecule-metal interfaces. Using the PennyLane software platform, we perform resource estimations of our algorithm, showing its remarkably low implementation cost for model systems representative of various scientifically and industrially relevant molecule-metal systems. Specifically, we find that time evolution for models including $100$ metal orbitals, $8$ molecular orbitals, and $20$ nuclear degrees of freedom, requires only $271$ qubits and $7.9 \times 10^7$ Toffoli gates for $1000$ Trotter steps, suggesting non-adiabatic molecule-metal dynamics as a fruitful application of first-generation fault-tolerant quantum computers.

quant-pharXiv:2601.16264•Jan 26, 2026•4 citations

Toward Accurate Calculation of Excitation Energies on Quantum Computers with ΔADAPT-VQE: A Case Study of BODIPY Derivatives

Anton Nykänen, Leander Thiessen, Elsi-Mari Borrelli +3 more

Quantum chemistry simulations offer a cost-effective way to computationally design BODIPY photosensitizers. However, accurate predictions of excitation energies pose a challenge for time-dependent density functional theory and equation-of-motion coupled-cluster singles and doubles methods. By contrast, reliable predictions can be achieved by multireference quantum chemistry methods; unfortunately, their computational cost increases exponentially with the number of electrons. Alternatively, quantum computing holds potential for an exact simulation of the photophysical properties in a computationally more efficient way. Herein, we introduce the state-specific ΔUCCSD-VQE (unitary coupled-cluster singles and doubles-variational quantum eigensolver) and ΔADAPT-VQE methods in which the electronically excited state is calculated via a non-Aufbau configuration. We show for six BODIPY derivatives that the proposed methods predict accurate excitation energies that are in good agreement with those from experiments. Due to its performance and simplicity, we believe that ΔADAPT will become a useful approach for the simulation of BODIPY photosensitizers on near-term quantum devices.

arXiv:2404.16149•The Journal of Physical Chemistry Letters•Jul 2, 2024•16 citations

Quantum computing in drug discovery

Harshraj N. Gadbail, Rajendra M. Rewatkar, Nishant Rajendra Jumde +3 more

Early-stage decisions in the pharmaceutical development process carry outsized consequences for eventual clinical success, yet the computational tools underpinning these decisions remain fundamentally constrained. Computer-aided drug design (CADD) has transformed how researchers navigate chemical space and predict ligand–target interactions, but classical implementations rely on mechanical force-field approximations that fail to capture polarisation, charge transfer, and electron correlation effects central to molecular recognition and reactivity. Quantum-mechanical treatments that correctly describe these phenomena scale exponentially with system size on classical hardware, rendering them impractical for drug-relevant biomolecules. Quantum computing offers a physically motivated path beyond this scaling barrier: by exploiting superposition, entanglement, and interference, quantum algorithms can in principle simulate electronic structure with polynomial resource requirements for targeted problem classes. This article provides a theoretical review of how quantum computation integrates throughout the drug discovery pipeline, from target identification to lead optimisation. Its primary contribution is a pipeline-level mapping of quantum methods—including the Variational Quantum Eigensolver (VQE), quantum machine learning, and quantum-enhanced optimisation—to specific drug development stages. The review critically distinguishes near-term NISQ (Noisy Intermediate-Scale Quantum: current devices with 50–1,000 noisy qubits operating without full error correction) capabilities from fault-tolerant quantum computing (FTQC) requirements, quantifies current resource gaps through a worked CYP3A4 case study, and identifies algorithmic limitations (barren plateaus, ansatz expressibility, measurement overhead), hardware scalability, and error correction overhead as the principal barriers to practical deployment.

Frontiers in Drug Discovery•Sep 7, 2026•0 citations

Harnessing Quantum Molecular Simulation for Accelerated Cancer Drug Screening

Salvation Ifechukwude Atalor, Onuh Mathew Ijiga, Joy Onma Enyejo

Cancer drug discovery is a resource-intensive process characterized by low success rates, protracted timelines, and significant cost implications. Conventional screening methods—including high-throughput assays and classical molecular modeling—struggle to capture the quantum nature of biomolecular interactions critical to binding affinity and drug specificity. In response, quantum molecular simulation (QMS) has emerged as a transformative approach that leverages the principles of quantum mechanics to enhance the accuracy and efficiency of drug-target interaction modeling. This review explores the theoretical foundations, computational methodologies, and real-world applications of QMS in cancer drug discovery. It discusses key quantum approaches such as Density Functional Theory (DFT), Hartree-Fock (HF), and hybrid QM/MM methods, while evaluating the role of quantum algorithms— including Variational Quantum Eigensolvers (VQE) and Quantum Phase Estimation (QPE)—in elucidating biomolecular structures and energetics. The integration of QMS with next-generation quantum hardware platforms (e.g., superconducting qubits and quantum annealers) and open-source software ecosystems is also reviewed. Comparative performance analyses highlight the advantages of QMS over classical methods in terms of precision, scalability, and its potential for personalized oncology applications. Nonetheless, significant challenges remain, including issues of decoherence, algorithmic noise, regulatory integration, and reproducibility. This paper presents a forward-looking perspective on how QMS, when synergized with artificial intelligence and omics data, could fundamentally reshape the paradigm of cancer therapeutic development by enabling faster, more accurate, and mechanism-driven drug discovery.

International Journal of Scientific Research and Modern Technology.•Jan 30, 2023•84 citations
Photodynamic therapy (PDT) is a targeted cancer treatment that uses light-activated photosensitizers to generate reactive oxygen species that selectively destroy tumor cells, generally causing less collateral damage than conventional treatments. However, its clinical success hinges on the availability of photosensitizers with strong optical sensitivity and high efficiency in generating reactive oxygen species. While classical computational methods have provided useful insights into photosensitizer design, they struggle to scale and often lack the accuracy needed for these simulations. In this work, we show how fault-tolerant quantum algorithms can be used to identify promising photosensitizer candidates for PDT. To predict photosensitizer performance, we assess two computational properties. First, we quantify light sensitivity by calculating the cumulative absorption in the therapeutic window with a threshold projection algorithm. Second, we determine the efficiency of reactive oxygen generation by estimating intersystem crossing (ISC) rates using the evolution-proxy approach, complemented by a vibronic dynamic treatment where appropriate. We apply these algorithms to a clinically relevant and actively pursued class of photosensitizers, BODIPY derivatives, including heavy-atom and transition-metal-substituted systems that are challenging for classical methods. Our resource estimates, obtained with PennyLane, suggest that systems with active spaces ranging from 11 to 45 spatial orbitals can be simulated using 180180180-350350350 logical qubits and Toffoli gate depths between 10710^7107 and 10910^9109, placing our algorithms within reach of realistic fault-tolerant quantum devices. This paves the way to an efficient quantum-based workflow for designing photosensitizers that can accelerate the discovery of new PDT agents.
We establish and analyse the performance and resource requirements of an end-to-end fault-tolerant quantum algorithm for computing the absorption spectrum and population dynamics of photoexcited pyrazine. The quantum circuit construction consists of initial state preparation using uniformly controlled rotations, the time-dependent Hamiltonian propagation based on the grid-based Split Operator Quantum Fourier Transform (SO-QFT) method, and cost-effective measurements including statistical and canonical phase estimation. We use classical emulations to validate the quantum resources required for the task, and propose generalised formulae for the qubit count and gate depth calculation. Simulating the vibronic dynamics of pyrazine in a low-dimensional abstraction requires 17-qubit circuits with a gate depth of O(105)\mathcal{O}(10^5)O(105), whereas a full-dimensional simulation of pyrazine in 24 modes requires at least 97-qubit circuits with a gate depth of O(106)\mathcal{O}(10^6)O(106). Our work provides a foundational framework for understanding high-dimensional wavepacket-based quantum simulations of photo-induced dynamics and vibronic spectra, anticipating future applications in the simulation of even larger molecular systems on fault-tolerant quantum computers.
The intersection of quantum computing and quantum chemistry represents a promising frontier for achieving quantum utility in domains of both scientific and societal relevance. Owing to the exponential growth of classical resource requirements for simulating quantum systems, quantum chemistry has long been recognized as a natural candidate for quantum computation. This perspective focuses on identifying scientifically meaningful use cases where early fault-tolerant quantum computers, which are considered to be equipped with approximately 25-100 logical qubits, could deliver tangible impact. While recent advances in classical computing have pushed the boundaries of tractable simulations to unprecedented scales, this logical-qubit regime represents the first window where quantum devices can pursue qualitatively distinct strategies, such as polynomial-scaling phase estimation, direct simulation of quantum dynamics, and active-space embedding, that remain challenging for classical solvers, such as multireference charge-transfer and conical-intersection states central to photochemistry and materials design. We highlight near-term opportunities in algorithm and software design, discuss representative chemical problems suited for quantum acceleration, and propose strategic roadmaps and collaborative pathways for advancing practical quantum utility in quantum chemistry.
Non-adiabatic dynamics at molecule-metal interfaces govern diverse and technologically important phenomena, from heterogeneous catalysis to dye-sensitized solar energy conversion and charge transport across molecular junctions. Realistic modeling of such dynamics necessitates taking into account various charge and energy transfer channels involving the coupling of nuclear motion with a very large number of electronic states, leading to prohibitive cost using classical computational methods. In this work we introduce a generalization of the Anderson-Newns Hamiltonian and develop a highly optimized quantum algorithm for simulating the non-adiabatic dynamics of realistic molecule-metal interfaces. Using the PennyLane software platform, we perform resource estimations of our algorithm, showing its remarkably low implementation cost for model systems representative of various scientifically and industrially relevant molecule-metal systems. Specifically, we find that time evolution for models including 100100100 metal orbitals, 888 molecular orbitals, and 202020 nuclear degrees of freedom, requires only 271271271 qubits and 7.9×1077.9 \times 10^77.9×107 Toffoli gates for 100010001000 Trotter steps, suggesting non-adiabatic molecule-metal dynamics as a fruitful application of first-generation fault-tolerant quantum computers.
Quantum chemistry simulations offer a cost-effective way to computationally design BODIPY photosensitizers. However, accurate predictions of excitation energies pose a challenge for time-dependent density functional theory and equation-of-motion coupled-cluster singles and doubles methods. By contrast, reliable predictions can be achieved by multireference quantum chemistry methods; unfortunately, their computational cost increases exponentially with the number of electrons. Alternatively, quantum computing holds potential for an exact simulation of the photophysical properties in a computationally more efficient way. Herein, we introduce the state-specific ΔUCCSD-VQE (unitary coupled-cluster singles and doubles-variational quantum eigensolver) and ΔADAPT-VQE methods in which the electronically excited state is calculated via a non-Aufbau configuration. We show for six BODIPY derivatives that the proposed methods predict accurate excitation energies that are in good agreement with those from experiments. Due to its performance and simplicity, we believe that ΔADAPT will become a useful approach for the simulation of BODIPY photosensitizers on near-term quantum devices.
Early-stage decisions in the pharmaceutical development process carry outsized consequences for eventual clinical success, yet the computational tools underpinning these decisions remain fundamentally constrained. Computer-aided drug design (CADD) has transformed how researchers navigate chemical space and predict ligand–target interactions, but classical implementations rely on mechanical force-field approximations that fail to capture polarisation, charge transfer, and electron correlation effects central to molecular recognition and reactivity. Quantum-mechanical treatments that correctly describe these phenomena scale exponentially with system size on classical hardware, rendering them impractical for drug-relevant biomolecules. Quantum computing offers a physically motivated path beyond this scaling barrier: by exploiting superposition, entanglement, and interference, quantum algorithms can in principle simulate electronic structure with polynomial resource requirements for targeted problem classes. This article provides a theoretical review of how quantum computation integrates throughout the drug discovery pipeline, from target identification to lead optimisation. Its primary contribution is a pipeline-level mapping of quantum methods—including the Variational Quantum Eigensolver (VQE), quantum machine learning, and quantum-enhanced optimisation—to specific drug development stages. The review critically distinguishes near-term NISQ (Noisy Intermediate-Scale Quantum: current devices with 50–1,000 noisy qubits operating without full error correction) capabilities from fault-tolerant quantum computing (FTQC) requirements, quantifies current resource gaps through a worked CYP3A4 case study, and identifies algorithmic limitations (barren plateaus, ansatz expressibility, measurement overhead), hardware scalability, and error correction overhead as the principal barriers to practical deployment.
Cancer drug discovery is a resource-intensive process characterized by low success rates, protracted timelines, and significant cost implications. Conventional screening methods—including high-throughput assays and classical molecular modeling—struggle to capture the quantum nature of biomolecular interactions critical to binding affinity and drug specificity. In response, quantum molecular simulation (QMS) has emerged as a transformative approach that leverages the principles of quantum mechanics to enhance the accuracy and efficiency of drug-target interaction modeling. This review explores the theoretical foundations, computational methodologies, and real-world applications of QMS in cancer drug discovery. It discusses key quantum approaches such as Density Functional Theory (DFT), Hartree-Fock (HF), and hybrid QM/MM methods, while evaluating the role of quantum algorithms— including Variational Quantum Eigensolvers (VQE) and Quantum Phase Estimation (QPE)—in elucidating biomolecular structures and energetics. The integration of QMS with next-generation quantum hardware platforms (e.g., superconducting qubits and quantum annealers) and open-source software ecosystems is also reviewed. Comparative performance analyses highlight the advantages of QMS over classical methods in terms of precision, scalability, and its potential for personalized oncology applications. Nonetheless, significant challenges remain, including issues of decoherence, algorithmic noise, regulatory integration, and reproducibility. This paper presents a forward-looking perspective on how QMS, when synergized with artificial intelligence and omics data, could fundamentally reshape the paradigm of cancer therapeutic development by enabling faster, more accurate, and mechanism-driven drug discovery.